Proper Name: Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant Tradename: Cervarix Manufacturer: GlaxoSmithKline Biologicals 16 October 2009, Cervarix® was approved for use in the United States, by the FDA. To examine all available FDA documents pertaining to the approval of this HPV vaccine visit the two FDA links below. Proper Name: Human Papillomavirus […]
Cervarix
Cervarix® is manufactured by GlaxoSmithKline. For information on this bivalent HPV vaccine directly from the source, visit their website here.
PRESCRIBING INFORMATION FOR CERVARIX
INDICATIONS AND USAGE CERVARIX® is indicated for the prevention of the following diseases caused by oncogenic human papillomavirus (HPV) types 16 and 18 [see Clinical Studies (14)]: Cervical cancer Cervical intraepithelial neoplasia (CIN) grade 2 or worse and adenocarcinoma in situ, and Cervical intraepithelial neoplasia (CIN) grade 1. CERVARIX is approved for use in females […]
A Judicial Watch Special Report: Examining the FDA’s HPV Vaccine Records
Detailing the Approval Process, Side-Effects, Safety Concerns and Marketing Practices of a Large-Scale Public Health Experiment June 30, 2008 This Judicial Watch Special Report is an analysis of records obtained from the Food and Drug Administration (FDA) concerning a recent vaccine called Gardasil. Gardasil helps protect against four types of human papillomavirus (HPV). The […]
Gardasil Blood Clots Are A Potential Risk Associated With Gardasil
30.07.2010 | Author: vaccineinjuryhelpcenter | Posted in Health & Fitness Gardasil blood clots and other serious side effects have been associated with Gardasil. Gardasil is a vaccine designed to prevent certain types of human papillomavirus (HPV). These HPV types are associated with a great percentage of cervical cancer cases as well as a smaller percentage of […]
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- Next Page »